Ubs Oconnor LLC Humacyte, Inc. Transaction History

Ubs Oconnor LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $615,890 - $2.59 Million	-504,828 Reduced 45.89%	595,172 $1.94 Billion
Q2 2022 Aug 12, 2022	SELL	$3.21 - $7.86 $590,733 - $1.45 Million	-184,029 Reduced 14.33%	1,100,000 $3.53 Million
Q1 2022 May 16, 2022	BUY	$4.65 - $7.4 $1.79 Million - $2.84 Million	383,929 Added 42.65%	1,284,029 $9.07 Million
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $6.53 Million - $10.4 Million	900,100 New	900,100 $6.53 Million

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $475M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.